| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |